Serotonin/Tryptophan ratio
|
Basic information |
| Metabolite name | Serotonin/Tryptophan ratio |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | NA |
| No. of studies | 11 |
|
Basic information |
| Metabolite name | Serotonin/Tryptophan ratio |
| N/A |
|
N/A |
|
N/A |
| Synonyms | NA |
| No. of studies | 11 |
|
Relationship between Serotonin/Tryptophan ratio and depression (count: 11) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M079 | Type1 | acute LPS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M079 | Type1 | prolonged LPS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M1081 | Type1 | CUMS group vs. control group | Colon | C57BL/6 J mouse | Down |
| Study M1081 | Type1 | CUMS group vs. control group | Serum | C57BL/6 J mouse | Down |
| Study M1081 | Type2 | CUMS + 1-methyl-tryptophan group vs. CUMS group | Serum | C57BL/6 J mouse | Up |
| Study M1081 | Type2 | CUMS + 1-methyl-tryptophan group vs. CUMS group | Colon | C57BL/6 J mouse | Up |
| Study M1081 | Type3 | 1-methyl-tryptophan group vs. control group | Colon | C57BL/6 J mouse | Up |
| Study M1082 | Type1 | interferon gamma group vs. control group | Brain | C57BL/6 J mouse | Down |
| Study M1082 | Type1 | interferon gamma group vs. control group | Colon | C57BL/6 J mouse | Down |
| Study M1082 | Type1 | interferon gamma group vs. control group | Serum | C57BL/6 J mouse | Down |
| Study M1082 | Type2 | interferon gamma + Pulsatilla chinensis saponins group vs. interferon gamma group | Brain | C57BL/6 J mouse | Up |
| Study M1082 | Type2 | interferon gamma + Pulsatilla chinensis saponins group vs. interferon gamma group | Serum | C57BL/6 J mouse | Up |
| Study M1082 | Type2 | interferon gamma + 1-methyl-tryptophan group vs. interferon gamma group | Colon | C57BL/6 J mouse | Up |
| Study M1082 | Type2 | interferon gamma + Pulsatilla chinensis saponins group vs. interferon gamma group | Colon | C57BL/6 J mouse | Up |
| Study M1082 | Type2 | interferon gamma + 1-methyl-tryptophan group vs. interferon gamma group | Brain | C57BL/6 J mouse | Up |
| Study M1082 | Type2 | interferon gamma + 1-methyl-tryptophan group vs. interferon gamma group | Serum | C57BL/6 J mouse | Up |
| Study M1083 | Type1 | CUMS group vs. control group | Colon | C57BL/6 J mouse | Down |
| Study M1083 | Type1 | CUMS group vs. control group | Brain | C57BL/6 J mouse | Down |
| Study M1083 | Type2 | CUMS + Pulsatilla chinensis saponins group vs. CUMS group | Brain | C57BL/6 J mouse | Up |
| Study M1083 | Type2 | CUMS + Pulsatilla chinensis saponins group vs. CUMS group | Colon | C57BL/6 J mouse | Up |
| Study M1083 | Type2 | CUMS + Pulsatilla chinensis saponins group vs. CUMS group | Serum | C57BL/6 J mouse | Up |
| Study M1084 | Type1 | CUMS group vs. control group | Colon | C57BL/6 J mouse | Down |
| Study M1084 | Type1 | CUMS group vs. control group | Brain | C57BL/6 J mouse | Down |
| Study M1084 | Type2 | CUMS + Mesalazine group vs. CUMS group | Brain | C57BL/6 J mouse | Up |
| Study M1084 | Type2 | CUMS + Mesalazine group vs. CUMS group | Colon | C57BL/6 J mouse | Up |
| Study M1138 | Type1 | unpredictable subchronic stress group vs. control group | Hippocampus | Swiss mouse | Up |
| Study M1138 | Type2 | unpredictable subchronic stress + imipramine group vs. unpredictable subchronic stress group | Hippocampus | Swiss mouse | Down |
| Study M728 | Type1 | CRS group vs. control group | Prefrontal cortex | C57BL/6 J mouse | Down |
| Study M728 | Type1 | CRS group vs. control group | Duodenum | C57BL/6 J mouse | Down |
| Study M728 | Type1 | CRS group vs. control group | Colon | C57BL/6 J mouse | Down |
| Study M829 | Type1 | CUMS group vs. control group | Liver | C57BL/6J mouse | Down |
| Study M829 | Type2 | CUMS + Xiaoyao Powder group vs. CUMS group | Liver | C57BL/6J mouse | Up |
| Study M829 | Type2 | CUMS + Sini Powder group vs. CUMS group | Liver | C57BL/6J mouse | Up |
| Study M829 | Type2 | CUMS + Chaihu Shugan Powder group vs. CUMS group | Liver | C57BL/6J mouse | Up |
| Study M983 | Type2 | adolescent MDD group, post-treatment vs. baseline | Plasma | Human | Up |
| Study M992 | Type1 | pilocarpine group vs. control group | Hippocampus | Wistar rat | Down |
| Study M992 | Type2 | pilocarpine + minocycline group vs. pilocarpine group | Hippocampus | Wistar rat | Up |
| Study M992 | Type2 | pilocarpine + 1-methyltryptophan group vs. pilocarpine group | Hippocampus | Wistar rat | Up |
| Study M996 | Type1 | CUMS group vs. control group | Serum | C57BL/6J mouse | Down |